CVE-2024-37389

Apache NiFi: Improper Neutralization of Input in Parameter Context Description

Description

Apache NiFi 1.10.0 through 1.26.0 and 2.0.0-M1 through 2.0.0-M3 support a description field in the Parameter Context configuration that is vulnerable to cross-site scripting. An authenticated user, authorized to configure a Parameter Context, can enter arbitrary JavaScript code, which the client browser will execute within the session context of the authenticated user. Upgrading to Apache NiFi 1.27.0 or 2.0.0-M4 is the recommended mitigation.

Category

4.6
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.11%
Vendor Advisory apache.org
Affected: Apache Software Foundation Apache NiFi
Published at:
Updated at:

References

Link Tags
https://lists.apache.org/thread/yso9fr0wtff53nk046h1o83hdyb1lrxh mailing list vendor advisory
http://www.openwall.com/lists/oss-security/2024/07/08/1

Frequently Asked Questions

What is the severity of CVE-2024-37389?
CVE-2024-37389 has been scored as a medium severity vulnerability.
How to fix CVE-2024-37389?
To fix CVE-2024-37389, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2024-37389 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2024-37389 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-37389?
CVE-2024-37389 affects Apache Software Foundation Apache NiFi.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.